Literature DB >> 24319298

Enantioselective synthesis of (10S)- and (10R)-methyl-anandamides.

Spyros P Nikas1, Marsha D'Souza, Alexandros Makriyannis.   

Abstract

For the development of novel endocannabinoid templates with potential resistance to hydrolytic and oxidative metabolism, we are targeting the bis-allylic carbons of the arachidonoyl skeleton. Toward this end, we recently disclosed the synthesis and preliminary biological data for the (13S)-methyl-anandamide. We report now the total synthesis of the (10S)- and (10R)-methyl-counterparts. Our synthetic approach is stereospecific, efficient, and provides the analogs without the need for resolution. Peptide coupling, P-2 nickel partial hydrogenation, and cis-selective Wittig olefination are the key steps.

Entities:  

Keywords:  Enantioselective synthesis; Endocannabinoids; Lipids; Methyl-anandamide

Year:  2012        PMID: 24319298      PMCID: PMC3849710          DOI: 10.1016/j.tet.2012.05.010

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  41 in total

1.  Observational analysis of feeding induced by Delta9-THC and anandamide.

Authors:  Claire M Williams; Tim C Kirkham
Journal:  Physiol Behav       Date:  2002-06-01

2.  Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity.

Authors:  David A Karanian; Queenie B Brown; Alexandros Makriyannis; Therese A Kosten; Ben A Bahr
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

3.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Authors:  D Panikashvili; C Simeonidou; S Ben-Shabat; L Hanus; A Breuer; R Mechoulam; E Shohami
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

4.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

5.  The endogenous cannabinoid system protects against colonic inflammation.

Authors:  Federico Massa; Giovanni Marsicano; Heike Hermann; Astrid Cannich; Krisztina Monory; Benjamin F Cravatt; Gian-Luca Ferri; Andrei Sibaev; Martin Storr; Beat Lutz
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

6.  Brain monoglyceride lipase participating in endocannabinoid inactivation.

Authors:  T P Dinh; D Carpenter; F M Leslie; T F Freund; I Katona; S L Sensi; S Kathuria; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

7.  (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability.

Authors:  V Abadji; S Lin; G Taha; G Griffin; L A Stevenson; R G Pertwee; A Makriyannis
Journal:  J Med Chem       Date:  1994-06-10       Impact factor: 7.446

Review 8.  Oxidative metabolism of endocannabinoids.

Authors:  K R Kozak; L J Marnett
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Feb-Mar       Impact factor: 4.006

Review 9.  The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action.

Authors:  C J Fowler
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

10.  Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor.

Authors:  A J Hampson; W A Hill; M Zan-Phillips; A Makriyannis; E Leung; R M Eglen; L M Bornheim
Journal:  Biochim Biophys Acta       Date:  1995-11-16
View more
  2 in total

1.  Design and synthesis of novel prostaglandin E2 ethanolamide and glycerol ester probes for the putative prostamide receptor(s).

Authors:  Erin L Shelnut; Spyros P Nikas; David F Finnegan; Nan Chiang; Charles N Serhan; Alexandros Makriyannis
Journal:  Tetrahedron Lett       Date:  2015-03-11       Impact factor: 2.415

2.  Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues.

Authors:  Shashank Kulkarni; Spyros P Nikas; Rishi Sharma; Shan Jiang; Carol A Paronis; Michael Z Leonard; Bin Zhang; Chandrashekhar Honrao; Srikrishnan Mallipeddi; Jimit Girish Raghav; Othman Benchama; Torbjörn U C Järbe; Jack Bergman; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2016-07-13       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.